Abstract It has so far been difficult to identify genes behind polygenic autoimmune diseases such as rheumatoid arthritis (RA), multiple sclerosis (MS), and type I diabetes (T1D). With proper animal models, some of the complexity behind these diseases can be reduced. The use of linkage analysis and positional cloning of genes in animal models for RA resulted in the identification of one of the genes regulating severity of arthritis in rats and mice, the Ncf1 gene. The Ncf1 gene encodes for the Ncf1 protein that is involved in production of free oxygen radicals through the NADPH oxidase complex, which opens up a new pathway for therapeutic treatment of inflammatory diseases. In most cases, however, a quantitative trait locus (QTL) is the sum effect of several genes within and outside the QTL, which make positional cloning
Introduction
The major autoimmune diseases such as rheumatoid arthritis (RA), multiple sclerosis, (MS) and type I diabetes (T1D) as well as related inflammatory disorders such as asthma, psoriasis, and atherosclerosis are complex, and it has been difficult to understand their fundamental genetic and environmental causes. With proper animal models genetic and environmental factors can be better controlled and also manipulated. This enables genetic approaches that lead to an insight not possible to achieve with direct human studies only. The possibility of combining the genetic knowledge with direct animal studies will enhance the understanding of these diseases and shorten the time needed to develop new therapies with higher efficiency and limited side-effects. We will discuss these possibilities, mainly using examples from recent studies of models for RA.
Definition of Autoimmune Disease: Physiology Versus Pathology
Identification of genes controlling autoimmune diseases requires that we have a clear definition of what an autoimmune disease is. Over the years, this definition has been shifting and also varies depending on whether it is seen from a clinical point of view or from a basic science point of view. From a clinical point of view, these diseases are inflammatory diseases of unknown origin, which cannot be explained by any obvious cause such as infection or allergen exposure. To strengthen the classification they should be chronic, i.e. they should last for a period that exceeds a normal acute inflammatory phase of usually 3-4 weeks. The occurrence of autoantibodies targeting some relevant tissue antigen is often, but not always, included as an additional criteria . However, the pathogenic relevance of such antibodies is not always clear. These definitions have led us to classify a number of commonly occurring chronic diseases as classical autoimmune, for example MS, RA, T1D, and systemic lupus erythematosus (SLE). A borderline group is made up of inflammatory diseases with a possible but not proven infectious cause such as spondyloarthropathies and inflammatory bowel diseases. Another borderline group comprises diseases in which an inflammatory component
